Delhi: Industry body Assocham has said that the Indian
pharma industry would grow at 11 per cent to touch Rs60,000
crore in 2007-08 from Rs39,000 crore in 2003-04, when
drugs worth US$65bn would go off patent.
exports from India would grow at 18 per cent to touch
volume of Rs30,000 crore in 2007-08 from Rs15,500 crore
during 2003-04, according to a study released by Assocham
in New Delhi on Tuesday.
study also points out that globally drugs worth US$40bn
would go off patent this year and another US$70bn dollar
would go off patent in 2008. Indian pharma companies would
then raise their stake in the world market to 30 per cent,
companies could leverage their strength in terms of low
of production and availability of quality manpower as
domestic production cost was 50 per cent less as compared
to developed countries, it said.